Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 2,984 shares at $45.06 ($134K) on 2024-02-01, disclosed to the SEC on 2024-02-05.
Open-market sale of $134k RYTM by EVP, Head of North America. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.06 | 1,492 | $67K | 50.0% |
| 2 | $45.06 | 1,492 | $67K | 50.0% |
| Total | $45.06 avg | 2,984 | $134K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-14 | $240K | — | Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |